MTNB (Matinas BioPharma Holdings, Inc.) Stock Analysis - Insider Trades

Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded Healthcare sector company. As of May 21, 2026, MTNB trades at $0.64 with a market cap of $3.46M and a P/E ratio of -0.30. MTNB moved +14.52% today. Year to date, MTNB is -0.64%; over the trailing twelve months it is -16.08%. Its 52-week range spans $0.47 to $4.25. Rallies surfaces MTNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MTNB stock inside the company?

Rallies tracks MTNB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

MTNB Key Metrics

Key financial metrics for MTNB
MetricValue
Price$0.64
Market Cap$3.46M
P/E Ratio-0.30
EPS$-2.00
Dividend Yield0.00%
52-Week High$4.25
52-Week Low$0.47
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-10.35M
Gross Margin0.00%

Latest MTNB News

MTNB Analyst Consensus

MTNB analyst coverage data. Average price target: $0.00.

Common questions about MTNB

Who is trading MTNB stock inside the company?
Rallies tracks MTNB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for MTNB?
Yes. Rallies tracks MTNB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MTNB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MTNB. It does not provide personalized investment advice.
MTNB

MTNB